| |
|
|
|
|
| November 19 ,
2009 | ISSUE NUMBER 124 VOL 7 |
R&D
Clinical Trials Find Drug Effective In Increasing Female Desire
Dubbed as the ‘female Viagra,’ Boehringer Ingelheim’s filbanserin represents an unprecedented step forward in treating female sexual dysfunction.
FDA
A Call for Social Media Guidelines
Nearly 70 pharma execs, new media mavens, and even Joe Q. Public packed last week’s FDA social media hearings to plead for some form of guidance on how to handle Tweets, blog comments, and off label discussions online.
Strategy
When Big Pharma Leaves Town
Wall Street smiles when a drug company gets with the program by “restructuring” and “rightsizing.” But for Main Street, the story of hundreds or thousands of sales reps and researchers getting kicked to the curb is quite different.
Marketing
Google Unveils New Pharma Ads
A few months back, the big G mentioned that it was working on ads to appease both pharmaceutical marketers and FDA. But at last week’s social media hearing the general public got to lay eyes on the new ad units.
Web Exclusive
Rising to the Challenge in R&D
Allosteric modulators are an emerging class of orally available small molecule drugs that may have multiple advantages compared to traditional drugs.
Podcast
Emerging Pharma Leadership Awards—Jennifer Spear Smith, Wyeth
Jennifer Smith, PhD, executive director, independent medical education of Wyeth, discusses the future role of CME in healthcare reform and gives advice on what makes a good CME professional.
New & Noteworthy
Lean Comes to Pharma
The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
|
Advertisement:
CBI’s 8th Annual Commercialization Strategies for Pharmaceutical Product Launches – December 8–9, 2009, Philadelphia, PA
Leverage Successful Product Planning, Marketing, Pricing and Reimbursement Strategies for Accelerated Product Uptake
Save $400 off of your registration fee!* Mention promotional code QDD993 when registering.
Call 800-817-8601 or visit
 www.cbinet.com/ProductLaunchEast
*Discount offer can not be combined with other discounts or applied to a current registration.
Offer not valid on workshop only or academic registrations.
|
 |
|  PureTech Ventures made John LaMattina, formerly with Pfizer, a senior partner // Biosyntrx promoted Ellen Troyer to CEO // Rules-Based Medicine hired Don Beamish as vice president, commercial development // Global consulting firm ZS Associates opens Spain office // CommonHealth won two bronze statuettes at the CLIO Healthcare Awards in New York City // Cardiac Science appointed Peter Kingma as senior vice president // TBWA Worldwide appointed Gary Wenzel as president, TBWA\WorldHealth //J.R. Meloro was named executive vice president, managing director of Medicus International New York // Trubion Pharmaceuticals appointed Steven Gillis, executive chairman of the board and acting president
|
December 2 Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset
Wednesday, December 2, 2009 at 11AM ET
December 3 Building Market Share Through Patient Segmentation Strategies: New Ideas and Best Practices to Enhance ROI
Thursday, December 3, 2009 at 11:30 AM ET
Register Free at www.pharmexec.com/marketshare
December 8 How Virtual Media Can Save the Medical Speaker Program
Tuesday, December 8, 2009 at 11:00 AM ET
Register Free at www.medpt.com/pharmexec/speaker
|
|
|
Nov 17–18, 2009 3rd Annual Evidence-Based Medicine and Comparative Effectiveness Research Summit for the Bio/Pharmaceutical and Medical Device Industries,
Philadelphia, PA
Dec 8–9, 2009 Forum on FDA’s Structured Product Labeling, Washington, DC
Jan 21–22, 2010 Bio/Pharmaceutical Forum on Optimizing the Use of Complex Data Assets,
Philadelphia, PA
Jan 25–26, 2010 Bio/Pharmaceutical Forum on Strategic Sourcing and Procurement,
Philadelphia, PA
Feb 8–9, 2010 3rd Annual Clinical Trial Forecasting and Budgeting, Philadelphia, PA |
|
|
|
 |
|
 |
|
 |
| Should FDA recognize social media as a new form of communication with its own rules and regulations? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
